» Articles » PMID: 28771198

Prevention of Gastric Cancer: Eradication of Helicobacter Pylori and Beyond

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2017 Aug 4
PMID 28771198
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Although its prevalence is declining, gastric cancer remains a significant public health issue. The bacterium is known to colonize the human stomach and induce chronic atrophic gastritis, intestinal metaplasia, and gastric cancer. Results using a Mongolian gerbil model revealed that infection increased the incidence of carcinogen-induced adenocarcinoma, whereas curative treatment of significantly lowered cancer incidence. Furthermore, some epidemiological studies have shown that eradication of reduces the development of metachronous cancer in humans. However, other reports have warned that human cases of atrophic metaplastic gastritis are already at risk for gastric cancer development, even after eradication of these bacteria. In this article, we discuss the effectiveness of eradication and the morphological changes that occur in gastric dysplasia/cancer lesions. We further assess the control of gastric cancer using various chemopreventive agents.

Citing Articles

Identifying the key role of mitochondrial respiration and lipid metabolism in regulating axillary osmidrosis through proteomics analysis.

Gao Q, Liu Y, Huang J, Wang L Arch Dermatol Res. 2024; 317(1):128.

PMID: 39673600 DOI: 10.1007/s00403-024-03616-7.


Experience of negative pressure fractional microneedle radiofrequency therapy for axillary osmidrosis: a case study.

Zhang Y, Li Y, Li C, Tian J Arch Dermatol Res. 2024; 317(1):66.

PMID: 39636411 DOI: 10.1007/s00403-024-03560-6.


lncRNA LINC02323 predicts adverse neoadjuvant chemotherapy outcomes of gastric cancer patients and regulates cell sensitivity to 5-fluorouracil by negatively modulating miR-139-3p.

Chen Z, Zhang X, Li Z, Zhang H, Wang Z Ann Med. 2024; 56(1):2424513.

PMID: 39506605 PMC: 11544739. DOI: 10.1080/07853890.2024.2424513.


Optimized sequential therapy 10- and 14-d concomitant therapy for eradicating : A randomized clinical trial.

Seddik H, Benass J, Berrag S, Sair A, Berraida R, Boutallaka H World J Gastroenterol. 2024; 30(6):556-564.

PMID: 38463026 PMC: 10921140. DOI: 10.3748/wjg.v30.i6.556.


Helicobacter pylori upregulates circPGD and promotes development of gastric cancer.

Zhao W, Yao Z, Cao J, Liu Y, Zhu L, Mao B J Cancer Res Clin Oncol. 2024; 150(2):104.

PMID: 38407616 PMC: 10896836. DOI: 10.1007/s00432-023-05537-w.


References
1.
Bae M, Jang S, Lim J, Kang J, Bak E, Cha J . Protective effect of Korean Red Ginseng extract against Helicobacter pylori-induced gastric inflammation in Mongolian gerbils. J Ginseng Res. 2014; 38(1):8-15. PMC: 3915327. DOI: 10.1016/j.jgr.2013.11.005. View

2.
Lee Y, Chen T, Chiu H, Shun C, Chiang H, Liu T . The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut. 2012; 62(5):676-82. PMC: 3618687. DOI: 10.1136/gutjnl-2012-302240. View

3.
Saka A, Yagi K, Nimura S . Endoscopic and histological features of gastric cancers after successful Helicobacter pylori eradication therapy. Gastric Cancer. 2015; 19(2):524-530. DOI: 10.1007/s10120-015-0479-y. View

4.
Ito M, Tanaka S, Takata S, Oka S, Imagawa S, Ueda H . Morphological changes in human gastric tumours after eradication therapy of Helicobacter pylori in a short-term follow-up. Aliment Pharmacol Ther. 2005; 21(5):559-66. DOI: 10.1111/j.1365-2036.2005.02360.x. View

5.
Marone P, Bono L, Leone E, Bona S, Carretto E, Perversi L . Bactericidal activity of Pistacia lentiscus mastic gum against Helicobacter pylori. J Chemother. 2002; 13(6):611-4. DOI: 10.1179/joc.2001.13.6.611. View